Fondazione Centro San Raffaele del Monte Tabor
Welcome,         Profile    Billing    Logout  
 14 Trials 
11 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Colombo, Antonio
AHEAD, NCT03339115: European Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System

Recruiting
N/A
30
Europe
Cardiovalve Transfemoral Mitral Valve
Cardiovalve Ltd., Meditrial Europe Ltd., Meditrial SrL
Mitral Regurgitation, Mitral Valve Disease
12/24
12/29
TWIST-PILOT-IT, NCT05010746: TVMR With the Innovalve System Trial - Pilot Study in Italy

Active, not recruiting
N/A
4
Europe
Innovalve TMVR system
Edwards Lifesciences
Mitral Valve Regurgitation (Degenerative or Functional)
05/24
10/29
DYNAMITE, NCT05464147: DYNAMX Bioadaptor ImplanTation for the trEatment of Complex Coronary Lesions

Active, not recruiting
N/A
55
Europe
DynamX Drug-Eluting Coronary Bioadaptor System
Elixir Medical Corporation, Istituto Clinico Humanitas
Coronary Artery Disease, Chronic Total Occlusion of Coronary Artery, Bifurcation of Coronary Artery, Multi Vessel Coronary Artery Disease, Long Lesions Coronary Artery Disease
03/24
10/24
DTU-STEMI, NCT03947619: Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial

Active, not recruiting
N/A
527
Europe, Canada, US
Impella CP® placement prior to reperfusion with Primary PCI
Abiomed Inc.
ST Elevation (STEMI) Myocardial Infarction of Anterior Wall
09/24
10/30
PROTECT IV, NCT04763200: Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function

Active, not recruiting
N/A
1252
Europe, Canada, US
Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®, IABP Intra-aortic balloon pump
Abiomed Inc.
Left Ventricular Dysfunction, Coronary Artery Disease
03/26
10/27
Bandello, Francesco
UplighTED, NCT06307626: A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease.

Recruiting
3
108
Europe, Japan, US, RoW
Efgartigimod PH20 SC, Placebo PH20 SC
argenx
Thyroid Eye Disease
02/26
10/27
ARCHER II, NCT06510816: A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of ANX007 in Participants With Geographic Atrophy (GA)

Recruiting
3
630
Europe, Canada, US, RoW
ANX007, Sham Administration
Annexon, Inc.
Geographic Atrophy
10/26
10/27
NCT04740671 / 2020-005364-57: A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD

Completed
3
410
Europe, US, RoW
HLX04-O, ranibizumab
Shanghai Henlius Biotech
Age Related Macular Degeneration
12/24
12/24
MIRAKLE, NCT06616922 / 2020-005263-31: Assessment of the Effects and Tolerability of RD03/2016 for the Treatment of Bacterial Conjunctivitis in Adults

Completed
2
252
Europe, RoW
RD03/2016 eye drops, Levofloxacin + Ketorolac Trometamol 0.5+0.5% w/v eye drops solution, Levofloxacin 0.5% eye drops solution (Oftaquix®), Oftaquix® 5 mg/ml eye drops solution
NTC srl, NTC s.r.l, NTC SRL, NTC s.r.l.
Conjunctivitis, Bacterial
06/23
09/23
NR, NCT04295304: 600 System Retinal Prosthesis for Patients With Retinal Degenerative Diseases

Terminated
N/A
9
Europe, RoW
Retinal surgery with implantation of epi-retinal device
Nano Retina, MedPass International
Retinitis Pigmentosa, Retinal Degeneration
03/23
03/23
Lazzarin, Adriano
NCT04090151: The RESPOND Outcomes Study

Recruiting
N/A
37853
Europe, RoW
Rigshospitalet, Denmark, Gilead Sciences, ViiV Healthcare
HIV
12/25
12/25
Monti, Giacomo
No trials found
CREMONA, George
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Colombo, Antonio
AHEAD, NCT03339115: European Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System

Recruiting
N/A
30
Europe
Cardiovalve Transfemoral Mitral Valve
Cardiovalve Ltd., Meditrial Europe Ltd., Meditrial SrL
Mitral Regurgitation, Mitral Valve Disease
12/24
12/29
TWIST-PILOT-IT, NCT05010746: TVMR With the Innovalve System Trial - Pilot Study in Italy

Active, not recruiting
N/A
4
Europe
Innovalve TMVR system
Edwards Lifesciences
Mitral Valve Regurgitation (Degenerative or Functional)
05/24
10/29
DYNAMITE, NCT05464147: DYNAMX Bioadaptor ImplanTation for the trEatment of Complex Coronary Lesions

Active, not recruiting
N/A
55
Europe
DynamX Drug-Eluting Coronary Bioadaptor System
Elixir Medical Corporation, Istituto Clinico Humanitas
Coronary Artery Disease, Chronic Total Occlusion of Coronary Artery, Bifurcation of Coronary Artery, Multi Vessel Coronary Artery Disease, Long Lesions Coronary Artery Disease
03/24
10/24
DTU-STEMI, NCT03947619: Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial

Active, not recruiting
N/A
527
Europe, Canada, US
Impella CP® placement prior to reperfusion with Primary PCI
Abiomed Inc.
ST Elevation (STEMI) Myocardial Infarction of Anterior Wall
09/24
10/30
PROTECT IV, NCT04763200: Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function

Active, not recruiting
N/A
1252
Europe, Canada, US
Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®, IABP Intra-aortic balloon pump
Abiomed Inc.
Left Ventricular Dysfunction, Coronary Artery Disease
03/26
10/27
Bandello, Francesco
UplighTED, NCT06307626: A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease.

Recruiting
3
108
Europe, Japan, US, RoW
Efgartigimod PH20 SC, Placebo PH20 SC
argenx
Thyroid Eye Disease
02/26
10/27
ARCHER II, NCT06510816: A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of ANX007 in Participants With Geographic Atrophy (GA)

Recruiting
3
630
Europe, Canada, US, RoW
ANX007, Sham Administration
Annexon, Inc.
Geographic Atrophy
10/26
10/27
NCT04740671 / 2020-005364-57: A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD

Completed
3
410
Europe, US, RoW
HLX04-O, ranibizumab
Shanghai Henlius Biotech
Age Related Macular Degeneration
12/24
12/24
MIRAKLE, NCT06616922 / 2020-005263-31: Assessment of the Effects and Tolerability of RD03/2016 for the Treatment of Bacterial Conjunctivitis in Adults

Completed
2
252
Europe, RoW
RD03/2016 eye drops, Levofloxacin + Ketorolac Trometamol 0.5+0.5% w/v eye drops solution, Levofloxacin 0.5% eye drops solution (Oftaquix®), Oftaquix® 5 mg/ml eye drops solution
NTC srl, NTC s.r.l, NTC SRL, NTC s.r.l.
Conjunctivitis, Bacterial
06/23
09/23
NR, NCT04295304: 600 System Retinal Prosthesis for Patients With Retinal Degenerative Diseases

Terminated
N/A
9
Europe, RoW
Retinal surgery with implantation of epi-retinal device
Nano Retina, MedPass International
Retinitis Pigmentosa, Retinal Degeneration
03/23
03/23
Lazzarin, Adriano
NCT04090151: The RESPOND Outcomes Study

Recruiting
N/A
37853
Europe, RoW
Rigshospitalet, Denmark, Gilead Sciences, ViiV Healthcare
HIV
12/25
12/25
Monti, Giacomo
No trials found
CREMONA, George
No trials found

Download Options